{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T19:11:31Z","timestamp":1792955491819,"version":"4.5.0"},"reference-count":71,"publisher":"Public Library of Science (PLoS)","issue":"3","content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0017617","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T19:05:15Z","timestamp":1300302315000},"page":"e17617","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease Pathogenesis"],"prefix":"10.1371","volume":"6","author":[{"given":"Catherine","family":"Emmanuel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Gava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary L.","family":"Balleine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghwa","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Wain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Hogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariush","family":"Etemadmoghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshy","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Australian Ovarian Cancer Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Birrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Chenevix-Trench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D. L.","family":"Bowtell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Harnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"deFazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,3,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation-a factor in ovarian neoplasia?","volume":"2","author":"MF Fathalla","year":"1971","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone.","volume":"90","author":"HA Risch","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1525-1438.1997.09756.x","article-title":"The epidemiology of epithelial ovarian cancer: a review.","volume":"7","author":"E Banks","year":"1997","journal-title":"Int J Gynecol Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(79)91435-1","article-title":"\u201cIncessant ovulation\u201d and ovarian cancer.","volume":"2","author":"JT Casagrande","year":"1979","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/gyno.1999.5628","article-title":"Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone.","volume":"76","author":"W Zheng","year":"2000","journal-title":"Gynecol Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/er.2006-0036","article-title":"Gonadotropins and ovarian cancer.","volume":"28","author":"JH Choi","year":"2007","journal-title":"Endocr Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ymgme.2005.06.007","article-title":"High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: implications for breast and ovarian cancer risk.","volume":"86","author":"H Jernstrom","year":"2005","journal-title":"Mol Genet Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1071-5576(98)00017-3","article-title":"Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis?","volume":"5","author":"GC Rodriguez","year":"1998","journal-title":"J Soc Gynecol Investig"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/1097-0142(19820215)49:4<722::AID-CNCR2820490421>3.0.CO;2-C","article-title":"Tumor markers in inclusion cysts of the ovary.","volume":"49","author":"A Blaustein","year":"1982","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube.","volume":"211","author":"Y Lee","year":"2007","journal-title":"J Pathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1158\/1078-0432.CCR-07-4959","article-title":"Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.","volume":"14","author":"AA Tone","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1158\/1078-0432.CCR-08-2525","article-title":"Estrous cycle modulates ovarian carcinoma growth.","volume":"15","author":"GN Armaiz-Pena","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1677\/JME-07-0149","article-title":"Global gene expression profiles of ovarian surface epithelial cells in vivo.","volume":"40","author":"N Gava","year":"2008","journal-title":"J Mol Endocrinol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1158\/0008-5472.CAN-05-2240","article-title":"Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.","volume":"65","author":"T Bonome","year":"2005","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.1038\/sj.onc.1207959","article-title":"Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways.","volume":"23","author":"H Donninger","year":"2004","journal-title":"Oncogene"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.","volume":"14","author":"RW Tothill","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1158\/1078-0432.CCR-04-0073","article-title":"Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer.","volume":"10","author":"VA Heinzelmann-Schwarz","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1158\/1078-0432.CCR-03-0409","article-title":"Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.","volume":"10","author":"KH Lu","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response.","volume":"98","author":"VG Tusher","year":"2001","journal-title":"PNAS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<893::AID-CNCR14>3.0.CO;2-W","article-title":"Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up.","volume":"82","author":"Y Shimizu","year":"1998","journal-title":"Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/jnci\/92.18.1534","article-title":"Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup.","volume":"92","author":"I Vergote","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e11408","DOI":"10.1371\/journal.pone.0011408","article-title":"Copy number analysis identifies novel interactions between genomic loci in ovarian cancer.","volume":"5","author":"KL Gorringe","year":"2010","journal-title":"PLoS ONE"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"20007","DOI":"10.1073\/pnas.0710052104","article-title":"Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma.","volume":"104","author":"R Beroukhim","year":"2007","journal-title":"PNAS"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrc1299","article-title":"A census of human cancer genes.","volume":"4","author":"PA Futreal","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes.","volume":"446","author":"C Greenman","year":"2007","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.bjc.6602332","article-title":"Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters.","volume":"92","author":"G Ferrandina","year":"2005","journal-title":"Br J Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ygyno.2006.03.035","article-title":"Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.","volume":"103","author":"G Spizzo","year":"2006","journal-title":"Gynecol Oncol"},{"key":"ref28","first-page":"315","article-title":"Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.","volume":"21","author":"L Sui","year":"2002","journal-title":"Int J Oncol"},{"key":"ref29","first-page":"211","article-title":"Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma.","volume":"10","author":"N Takai","year":"2002","journal-title":"Int J Mol Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.onc.1202367","article-title":"Constitutive activation of the 41-\/43-kDa mitogen-activated protein kinase signaling pathway in human tumors.","volume":"18","author":"R Hoshino","year":"1999","journal-title":"Oncogene"},{"key":"ref31","first-page":"560","article-title":"Loss of BRG1\/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.","volume":"63","author":"DN Reisman","year":"2003","journal-title":"Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/(SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.0.CO;2-F","article-title":"Heterogeneous expression of the lipocalin NGAL in primary breast cancers.","volume":"79","author":"SP Stoesz","year":"1998","journal-title":"Int J Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer.","volume":"419","author":"S Varambally","year":"2002","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ijc.23287","article-title":"Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.","volume":"122","author":"SJ Jordan","year":"2008","journal-title":"Int J Cancer"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10549-008-0242-8","article-title":"Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients.","volume":"118","author":"B Gyorffy","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/1471-2407-10-497","article-title":"MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.","volume":"10","author":"JA Byrne","year":"2010","journal-title":"BMC Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0002-9440(10)64398-2","article-title":"CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.","volume":"161","author":"G Kristiansen","year":"2002","journal-title":"Am J Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1080\/14653240902878308","article-title":"Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.","volume":"11","author":"D Su","year":"2009","journal-title":"Cytotherapy"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/onc.2010.35","article-title":"CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.","volume":"29","author":"MQ Gao","year":"2010","journal-title":"Oncogene"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1007\/s00018-010-0420-9","article-title":"Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line.","volume":"67","author":"MF Shi","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.humpath.2004.04.014","article-title":"Expression of candidate tumor markers in ovarian carcinoma and benign ovary: Evidence for a link between epithelial phenotype and neoplasia.","volume":"35","author":"R Drapkin","year":"2004","journal-title":"Hum Pathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00129039-200403000-00008","article-title":"Immunohistochemical localization of survivin in serous tumors of the ovary.","volume":"12","author":"B Tringler","year":"2004","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1158\/1078-0432.CCR-06-2769","article-title":"Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I\/II study.","volume":"13","author":"A Burges","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1158\/1535-7163.MCT-05-0423","article-title":"Survivin and Granzyme B-induced apoptosis, a novel anticancer therapy.","volume":"5","author":"H Caldas","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.","volume":"100","author":"CG Kleer","year":"2003","journal-title":"PNAS"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000064638","article-title":"Increased expression but not genetic alteration of BRG1, a component of the SWI\/SNF complex, is associated with the advanced stage of human gastric carcinomas.","volume":"69","author":"K Sentani","year":"2001","journal-title":"Pathobiology"},{"key":"ref47","first-page":"21","article-title":"Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: Effects on prognosis and cell invasion.","volume":"127","author":"MK Siu","year":"2009","journal-title":"Int J Cancer"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1210\/me.2004-0082","article-title":"Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1\/2 on cancer cell proliferation.","volume":"18","author":"R Steinmetz","year":"2004","journal-title":"Mol Endocrinol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1677\/ERC-09-0308","article-title":"Follicle-stimulating hormone inhibits ovarian cancer cell apoptosis by upregulating survivin and downregulating PDCD6 and DR5.","volume":"18","author":"Y Huang","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1677\/JOE-10-0128","article-title":"Sex hormone regulation of survivin gene expression.","volume":"207","author":"NH Nabilsi","year":"2010","journal-title":"J Endocrinol"},{"key":"ref51","first-page":"6171","article-title":"BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines.","volume":"60","author":"AK Wong","year":"2000","journal-title":"Cancer Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/ijc.22352","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition.","volume":"120","author":"R Lim","year":"2007","journal-title":"Int J Cancer"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1593\/neo.04277","article-title":"Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data.","volume":"6","author":"C Pilarsky","year":"2004","journal-title":"Neoplasia"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.","volume":"164","author":"M Shih Ie","year":"2004","journal-title":"Am J Pathol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1210\/en.2003-1199","article-title":"Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin.","volume":"145","author":"E Arimoto-Ishida","year":"2004","journal-title":"Endocrinology"},{"key":"ref56","first-page":"5243","article-title":"Diagnostic markers that distinguish colon and ovarian adenocarcinomas: Identification by genomic, proteomic, and tissue array profiling.","volume":"63","author":"S Nishizuka","year":"2003","journal-title":"Cancer Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1095\/biolreprod.106.051136","article-title":"PSPC1, NONO, and SFPQ are expressed in mouse Sertoli cells and may function as coregulators of androgen receptor-mediated transcription.","volume":"75","author":"S Kuwahara","year":"2006","journal-title":"Biol Reprod"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"46742","DOI":"10.1074\/jbc.M404334200","article-title":"Identification of SNF1\/AMP kinase-related kinase as an NF-kappaB-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness.","volume":"279","author":"P Legembre","year":"2004","journal-title":"J Biol Chem"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0002-9440(10)63370-6","article-title":"Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.","volume":"165","author":"AK Sood","year":"2004","journal-title":"Am J Pathol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.4161\/cbt.8.11.8523","article-title":"Dual targeting of EphA2 and FAK in ovarian carcinoma.","volume":"8","author":"MM Shahzad","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1097-2765(00)80182-3","article-title":"Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2.","volume":"4","author":"H Lee","year":"1999","journal-title":"Mol Cell"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.bjc.6605161","article-title":"BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers.","volume":"101","author":"YK Lee","year":"2009","journal-title":"Br J Cancer"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1158\/1535-7163.661.3.6","article-title":"Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells.","volume":"3","author":"EA Lee","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/MCB.25.2.740-750.2005","article-title":"Contribution of hCAP-D2, a non-SMC subunit of condensin I, to chromosome and chromosomal protein dynamics during mitosis.","volume":"25","author":"E Watrin","year":"2005","journal-title":"Mol Cell Biol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/jcp.20522","article-title":"Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: functional similarity to the human disease and identification of prospective tumoral markers and targets.","volume":"206","author":"U Urzua","year":"2006","journal-title":"J Cell Physiol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0090-8258(03)00262-2","article-title":"Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients.","volume":"90","author":"J Moilanen","year":"2003","journal-title":"Gynecol Oncol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1158\/0008-5472.925.65.3","article-title":"Transcriptional coactivator Drosophila eyes absent homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growth.","volume":"65","author":"L Zhang","year":"2005","journal-title":"Cancer Res"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"26720","DOI":"10.1074\/jbc.272.42.26720","article-title":"Identification of several human homologs of hamster DNA damage-inducible transcripts. Cloning and characterization of a novel UV-inducible cDNA that codes for a putative RNA-binding protein.","volume":"272","author":"MS Sheikh","year":"1997","journal-title":"J Biol Chem"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1242\/jcs.01026","article-title":"Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism.","volume":"117","author":"S Wellmann","year":"2004","journal-title":"J Cell Sci"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/MCB.01386-08","article-title":"Cold-inducible RNA-binding protein bypasses replicative senescence in primary cells through extracellular signal-regulated kinase 1 and 2 activation.","volume":"29","author":"A Artero-Castro","year":"2009","journal-title":"Mol Cell Biol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.PGP.0000070851.25718.EC","article-title":"Expression of cold-inducible RNA-binding protein in the normal endometrium, endometrial hyperplasia, and endometrial carcinoma.","volume":"22","author":"AA Hamid","year":"2003","journal-title":"Int J Gynecol Pathol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0017617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T07:16:27Z","timestamp":1712301387000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0017617"}},"subtitle":[],"editor":[{"given":"Thomas","family":"Preiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,3,15]]},"references-count":71,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0017617","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,15]]}}}